Ameliorative effects of ethanolic leaf extract of azadirachta indica on renal histologic alterations in streptozotocin-induced diabetic rats

American Journal of Chinese Medicine

Volumn 39, Issue 5, 2011, Pages 903-916

  Akinola, Oluwole Busayo ^a   Zatta, Laura ^c   Dosumu, Olufunke Olubusola ^b   Akinola, Oluwafunmike Sharon ^a   Dini, Luciana ^c   Caxton Martins, Ezekiel Ademola ^a  

^a UNIVERSITY OF ILORIN   (Nigeria)

^b UNIVERSITY OF LAGOS   (Nigeria)

^c UNIVERSITY OF SALENTO   (Italy)

Author keywords

Azadirachta indica; Diabetes Mellitus; Glomerulosclerosis; Hyperglycemia; Kidney; Neem

Indexed keywords

AZADIRACHTA INDICA EXTRACT; CREATININE; GLUCOSE; GLUCOSE OXIDASE; METFORMIN; ORAL ANTIDIABETIC AGENT; PARAFFIN; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AZADIRACHTA INDICA; CELL VACUOLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; GLOMERULOSCLEROSIS; GLUCOSE BLOOD LEVEL; HISTOLOGY; HISTOPATHOLOGY; HYPERGLYCEMIA; KIDNEY FUNCTION; KIDNEY TUBULE CELL; MALE; NONHUMAN; PERIODIC ACID SCHIFF STAIN; PLANT LEAF; RAT; RENAL PROTECTION; STREPTOZOCIN DIABETES; UREA BLOOD LEVEL;

ANIMALS; AZADIRACHTA; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; HISTOLOGY; HUMANS; KIDNEY; MALE; PLANT EXTRACTS; PLANT LEAVES; RANDOM ALLOCATION; RATS; RATS, WISTAR;

EID: 80052631914     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X11009299     Document Type: Article

References (43)

1. Akinola, O.B., E.A. Caxton-Martins and L. Dini. Chronic treatment with ethanolic leaf extract of Azadirachta indica ameliorates lesions of pancreatic islets in streptozotocin diabetes. Int. J. Morphol. 28: 292-302, 2010.
2. Anjaneyulu, M. and K. Chopra. Quercetin, an antioxidant bioflavonoid, attenuates diabetic nephropathy in rats. Clin. Exp. Pharmacol. Physiol. 31: 244-248, 2004. (Pubitemid 38507865)
3. Asgary, S., G. Naderi, N. Sarrafzadegan, N. Ghassemi, M. Boshtam and A. Arefian. Anti-oxidant effect of flavonoids on haemoglobin glycosylation. Pharm. Acta Helv. 73: 223-226, 1999. (Pubitemid 29092750)
4. Azevedo, M. and S. Alla. Diabetes in Sub-Saharan Africa: Kenya, Mali, Mozambique, Nigeria, South Africa and Zambia. Int. J. Diabetes Dev. Ctries. 28: 101-108, 2008.
5. Chattopadhyay, R.R. Possible mechanism of antihyperglycaemic effect of Azadirachta indica leaf extract. Part IV. Gen. Pharmacol. 27: 431-434, 1996. (Pubitemid 26197892)
6. Chattopadhyay, R.R. Study of possible biochemical mode of anti-inflammatory action of Azadirachta indica in rats. Indian J. Exp. Biol. 36: 418-420, 1998.
7. Chattopadhyay, R.R. Possible mechanism of antihyperglycaemic effect of Azadirachta indica leaf extract, Part V. J. Ethnopharmacol. 67: 373-376, 1999. (Pubitemid 29469750)
8. Chen, L.E. and K. Breen. On the ability of four flavonoids, baicilein, luteolin, naringenin and quercetin to suppress the Fentone reaction of iron-ATP complex. Biometals 13: 77-83, 2000. (Pubitemid 30243039)
9. Cohen, M.P. and C.V. Klein. Glomerulopathy in rats with streptozotocin diabetes: Accumulation of glomerular basement membrane analogous to human diabetic nephropathy. J. Exp. Med. 149: 623-631, 1979. (Pubitemid 9137676)
10. Craven, P.A., C.M. Davidson and F.R. DeRubertis. Increase in diacylglycerol mass in isolated glomeruli by glucose from de novo synthesis of glycerolipids. Diabetes 39: 667-674, 2001.
11. da Silva, E.I., M.K. Piskula, N. Yamamoto, J.H. Moon and J. Terao. Quercetin metabolites inhibit copper ion-induced lipid peroxidation in rat plasma. FEBS Lett. 430: 405-408, 1998. (Pubitemid 28337954)
12. Diabetes Control and Complication Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329: 977-986, 1993.
13. Dijk, C. and T. Berl. Pathogenesis of diabetic nephropathy. Rev. Endocr. Metab. Disord. 5: 237-248, 2004. (Pubitemid 38903581)
14. Ebong, P.E., I.J. Atangwho and G.E. Egbung. The antidiabetic efficacy of combined extracts from two continental plants: Azadirachta indica (A. Juss) (Neem) and Vernonia amygdalina (Del.) (African Bitter Leaf). Am. J. Biochem. Biotechnol. 4: 239-244, 2008.
15. Ebstein, W. Weteres uber diabetes mellitus, insbesondere uber die Complication desselben mit typhus abdominis. Deutsches Arch. F. Klin. Med. 30: 1-44, 1882.
16. Gupta, S., M. Kataria, P.K. Gupta, S. Murganandan and R.C. Yashroy. Protective role of extract of neem seeds in diabetes caused by streptozotocin in rats. J. Ethnopharmacol. 90: 185-189, 2004. (Pubitemid 38175412)
17. Jung, D., H. Biggs, J. Erikson and P.U. Ledyard. New colorimetric reaction for end-point, continuous- flow, and kinetic measurement of urea. Clin. Chem. 21: 1136-1140, 1975.
18. Kang, J., X.S. Dai, T.B. Yu, B. Wen and Z.W. Yang. Glycogen accumulation in renal tubules, a key morphological change in the diabetic kidney. Acta Diabetol. 42: 110-116, 2005.
19. Khosla, P., S. Bhanwra, J. Singh, S. Seth and R.K. Srivastava. A study of hypoglycaemic effects of Azadirachta indica (neem) in normaland and alloxan diabetic rabbits. Indian J. Physiol. Pharmacol. 44: 69-74, 2000. (Pubitemid 30090036)
20. Kim, J., S. Kang, M. Park, T. Jung, H. Cho and S. Ku. Ameliorative antidiabetic activity of Dangnyosoko, Chinese herbal medicine in diabetic rats. Biosci. Biotechnol. Biochem. 71: 1527-1534, 2007. (Pubitemid 47012034)
21. Kimmelstiel, P. and C. Wilson. Intercapillary lesions in the glomeruli of the kidney. Am. J. Pathol. 12: 83-96, 1936.
22. Kock, K.F. and V. Vestergaard. Armanni-Ebstein lesions of the kidney: Diagnostic of death in diabetic coma? Forensic Sci. Int. 67: 169-174, 1994. (Pubitemid 24291042)
23. Lal, M.A., A. Korner, Y. Matsuo, S. Zelenin, S.X. Cheng, G. Jaremko, G.F. DiBona, A.C. Eklof and A. Aperia. Combined antioxidant and COMT inhibitor treatment reverses renal abnormalities in diabetic rats. Diabetes 49: 1381-1389, 2000. (Pubitemid 30624240)
24. Macedo, C.S., S.M. Capelletti, M.C. Mercadante, C.R. Padovani and C.T. Spadella. Role of metabolic control on diabetic nephropathy. Acta Cirurgica Brasileira 17: 370-375, 2002.
25. Murty, S.K., R.D. Narayana, R.D. Krishna and M.L. Gopalakrishna. A preliminary study on hypoglycaemic and antihyperglycaemic effect of Azadirachta indica. Indian J. Pharmacol. 10: 247-250, 1978.
26. Nobrega, M.A., S. Fleming, R.J. Roman, M. Shiozawa, N. Schlick, J. Lazar and H.J. Jacob. Initial characterisation of a rat model of diabetic nephropathy. Diabetes 53: 735-742, 2004. (Pubitemid 38270644)
27. Ohkubo, Y., H. Kishikawa and E. Araki. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study. Diabetes Res. Clin. Pract. 28: 103-107, 1995.
28. Penicaud, L., Y. Hitier, P. Ferre and J. Girard. Hypoglycaemic effect of metformin in genetically obese (fa/fa) rats results from an increased utilization of blood glucose by intestine. Biochem. J. 262: 881-885, 1989. (Pubitemid 19225163)
29. Rajs, G. and M. Mayer. Oxidation markedly reduces bilirubin interference in the Jaffe creatinine assay. Clin. Chem. 38: 2411-2413, 1992. (Pubitemid 23006202)
30. Rasch, R. Prevention of diabetic glomerulopathy in streptozotocin- diabetic rats by insulin treatment: The mesangial regions. Diabetologia 17: 243-248, 1979. (Pubitemid 10189644)
31. Ritchie, S. and D. Waugh. The pathology of Armanni-Ebstein nephropathy. Am. J. Pathol. 33: 1035-1043, 1957.
32. Robak, J. and R.J. Gryglewski. Flavonoids are scavengers of superoxide anions. Biochem. Pharmacol. 37: 837-841, 1988. (Pubitemid 18058453)
33. Saito, M., Y. Kinoshita, I. Satoh, C. Shinbori, T. Kono, T. Hanada, J. Uemasu, H. Suzuki, M. Yamada and K. Satoh. N-hexacosanol ameliorates STZ-induced diabetic rat nephropathy. Eur. J. Pharmacol. 544: 132-137, 2006. (Pubitemid 44148566)
34. Schafer, S., W. Linz, A. Bube, M. Gerl, J. Huber, G.U. Kurzel, M. Bleich, H.L. Schmidts, A.E. Busch and H. Rutten. Vasopeptidase inhibition prevents nephropathy in Zucker diabetic fatty rats. Cardiovasc. Res. 60: 447-454, 2003. (Pubitemid 37412379)
35. Schmidt, S., A. Ismail and E. Ritz. Diabetic glomerulopathy: Pathogenesis and management. Saudi J. Kidney Dis. Transplant. 11: 405-413, 2000.
36. Siddiqui, B.S., F. Afshan, T. Gulzar and M. Hanif. Tetracyclic triterpenoids from the leaves of Azadirachta indica. Phytochemistry 65: 2363-2367, 2004. (Pubitemid 39237253)
37. Srinivasan, K., C.L. Kaul and P. Ramarao. Partial protective effect of rutin on multiple low dose streptozotocin-induced diabetes in mice. Indian J. Pharmacol. 37: 327-328, 2005. (Pubitemid 41434091)
38. Szayna, M., M.E. Doyle, J.A. Betkey, H.W. Holloway, R.G. Spencer, N.H. Greig and J.M. Egan. Exendin-4 decelerates food intake, weight gain and fat deposition in Zucker rats. Endocrinology 141: 1936-1941, 2000. (Pubitemid 32274340)
39. Viberti, G., M.J. Wiseman, J.R. Pinto and J. Messent. Diabetic nephropathy. In: Joslin's Diabetic Nephropathy. Lippincott Williams and Wilkins, Philadelphia, 1994, pp. 691-737.
40. Wehner, H., W. Kosters, M. Strrauch and M. Staudenmeier. Effect of islet transplantation on the glomerular changes in streptozotocin diabetic rats. Virchow. Arch. A. Pathol. Anat. Histol. 388: 137-154, 1980. (Pubitemid 10061579)
41. Wilmer, W.A., C.L. Dixon and C. Hebert. Chronic exposure of human mesangial cell to high glucose environment activates the p38 MAPK pathway. Kidney Int. 60: 858-871, 2001. (Pubitemid 34205786)
42. Yamagishi, S.H., Y. Inagaki, T. Okamoto, S. Amano, K. Koga and M. Takeuchi. Advanced glycation end-products inhibit de novo protein synthesis and induce TGF-ß overexpression in proximal tubular cells. Kidney Int. 63: 464-473, 2003. (Pubitemid 36126793)
43. Ziyadeh, F. and D.C. Han. Involvement of TGF-ß and its receptors in the pathogenesis of diabetic nephropathy. Kidney Int. 60(Suppl.): S7-S11, 1997.